Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Comparing Copy Number Variations and SNPs02:26

Comparing Copy Number Variations and SNPs

18.5K
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
18.5K
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

15.1K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
15.1K
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

17.7K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
17.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Use of High-Efficacy Therapy in Children With Multiple Sclerosis to Prevent Long-Term Disability.

Neurology·2026
Same author

Comparative effectiveness of ocrelizumab in subgroups of patients with multiple sclerosis: a multi-registry observational cohort study.

Journal of neurology, neurosurgery, and psychiatry·2026
Same author

Predicting disease progression in multiple sclerosis with clinically accessible information and technology.

Journal of neurology·2026
Same author

Expression Analysis of Selected microRNAs in Diabetes Mellitus Visceral Fat Tissues.

Journal of obesity·2026
Same author

Corrigendum to "Real-world effectiveness of ocrelizumab in relapsing multiple sclerosis: An MSBase registry sub-study" [Multiple Sclerosis and Related Disorders Vol 106; Feb 2026; Article Number 106885].

Multiple sclerosis and related disorders·2026
Same author

Preserving Neurological Function in People at High and Low Risk of Aggressive Multiple Sclerosis: An Observational Cohort Study.

CNS drugs·2026

Related Experiment Video

Updated: Dec 22, 2025

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

10.5K

Replication analysis of variants associated with multiple sclerosis risk.

Mohammad Dashti1, Khadijah Ateyah2, Raed Alroughani3

  • 1Genetics and Bioinformatics department, Dasman Diabetes Institute, Sharq, Kuwait City, Kuwait.

Scientific Reports
|May 2, 2020
PubMed
Summary

Genetic factors influence Multiple Sclerosis (MS) risk in the Kuwaiti population. Variants in EVI5, MTHFR, and TNFRSF1A genes are identified as significant MS risk factors.

More Related Videos

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

34.5K
Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
11:35

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA

Published on: August 21, 2016

13.4K

Related Experiment Videos

Last Updated: Dec 22, 2025

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

10.5K
Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

34.5K
Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
11:35

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA

Published on: August 21, 2016

13.4K

Area of Science:

  • Neuroimmunology
  • Genetics
  • Epidemiology

Background:

  • Multiple Sclerosis (MS) is a chronic neurodegenerative disease driven by autoimmune responses against myelin.
  • Genetic associations with MS risk vary significantly across diverse populations.
  • Understanding population-specific genetic risk factors is crucial for targeted prevention and treatment strategies.

Purpose of the Study:

  • To investigate the association of established Multiple Sclerosis (MS) risk genetic variants within the Kuwaiti Arab population.
  • To identify specific genetic factors contributing to MS susceptibility in this demographic.
  • To validate findings from exome analysis through replication studies.

Main Methods:

  • Case-control study design comparing Kuwaiti MS patients and healthy controls.
  • Exome analysis of 94 reported MS risk variants.
  • Replication analysis to confirm associations of promising variants.

Main Results:

  • Four variants (EVI5 rs11808092, TNFRSF1A rs1800693, MTHFR rs1801131, CD58 rs1414273) initially showed association in Arab exome analysis.
  • Replication confirmed EVI5 rs11808092A (OR: 1.6, p=0.002) and MTHFR rs1801131G (OR: 1.79, p=0.001) as significant MS risk factors in Kuwait.
  • TNFRSF1A rs1800693C showed marginal association (OR: 1.36, p=0.025), while CD58 rs1414273 did not sustain risk association.

Conclusions:

  • EVI5 rs11808092A, TNFRSF1A rs1800693C, and MTHFR rs1801131G are confirmed MS risk factors in the Kuwaiti population.
  • These findings highlight population-specific genetic contributions to MS.
  • Further research is warranted to elucidate the roles of these variants in MS pathogenesis and progression.